Vosoritide: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Vosoritide. Educational only — not medical advice.
Labeled uses
VOXZOGO is indicated to increase linear growth in pediatric patients with achondroplasia with open epiphyses. This indication is approved under accelerated approval based on an improvement in annualized growth velocity [see Clinical Studies (14) ] . Continued approval for this indication may be contingent upon verification and description of clinical benefit in confirmatory trial(s).
Source: FDA labeling via NIH DailyMed (set 228e8560…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.